During the past decade, Vienna Institute for Research in Ocular Surgery (VIROS) conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 2 clinical trials were completed. i.e. 7.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vienna Institute for Research in Ocular Surgery (VIROS)" #1 sponsor was "Vienna Institute for Research in Ocular Surgery" with 37 trials, followed by "Prim. Prof. Dr. Oliver Findl, MBA" with 24 trials sponsored, "Croma-Pharma GmbH" with 2 trials sponsored, "Medical University of Vienna" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vienna Institute for Research in Ocular Surgery (VIROS)" #1 collaborator was "European Society of Cataract and Refractive Surgeons" with 2 trials as a collaborator and "ESCRS" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vienna Institute for Research in Ocular Surgery (VIROS)" are "Cataract" (32 trials), "Epiretinal Membrane" (7 trials), "Eye Diseases" (5 trials), "Cataract Senile" (3 trials) and "Astigmatism" (2 trials). Many other conditions were trialed in "Vienna Institute for Research in Ocular Surgery (VIROS)" in a lesser frequency.

Most popular intervention types in "Vienna Institute for Research in Ocular Surgery (VIROS)" are "Device" (37 trials), "Procedure" (17 trials), "Other" (13 trials), "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cataract surgery" (7 trials), "Lacrimera" (4 trials), "Placebo" (3 trials), "Bromfenac" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vienna Institute for Research in Ocular Surgery (VIROS)" are 69 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vienna Institute for Research in Ocular Surgery (VIROS)". undefined are not yet recruiting, 15 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Vienna Institute for Research in Ocular Surgery (VIROS), undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vienna Institute for Research in Ocular Surgery (VIROS), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 52 trials that are defined as “Not Applicable".